Supplementary Data from Multiple Repair Pathways Mediate Tolerance to Chemotherapeutic Cross-linking Agents in Vertebrate Cells (original) (raw)

Data from Multiple Repair Pathways Mediate Tolerance to Chemotherapeutic Cross-linking Agents in Vertebrate Cells

Alihossein Saberi

View PDFchevron_right

Multiple Repair Pathways Mediate Tolerance to Chemotherapeutic Cross-linking Agents in Vertebrate Cells

Alihossein Saberi, Hiroshi Arakawa

Cancer Research, 2005

View PDFchevron_right

ASSUMED GENOTOXIC EFFECTS OF VINCRISTINE-INDUCED TOXICITY IN MICE

Dr. Mohammad C Jamali

JOURNAL OF BIO INNOVATION, 2017

View PDFchevron_right

More Related Gene Pathways to Vincristine-Induced Death Events in a Human T-Acute Lymphoblastic Leukemia Cell Line

Azam Rashidbaghan

Reports of Biochemistry and Molecular Biology, 2022

View PDFchevron_right

Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine

Ashish Aggarwal

Investigational New Drugs, 2008

View PDFchevron_right

Cytotoxicity of Vincristine on the 5637 Cell Line Is Enhanced by Combination with Conferone

Samaneh Mollazadeh

View PDFchevron_right

Selective Enhancement of Vincristine Cytotoxicity in Multidrug-resistant Tumor Cells by Dilantin (Phenytoin)

Aleck Hercbergs

Cancer Research, 1993

View PDFchevron_right

Uptake and binding of vincristine by murine leukemia cells

Archie Bleyer

Biochemical Pharmacology, 1975

View PDFchevron_right

Vincristine cellular pharmacokinetic changes associated with multidrug resistance

Carles Domenech

European Journal of …, 1993

View PDFchevron_right

Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine

Carles Domenech

British Journal of Pharmacology, 1988

View PDFchevron_right

DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard

kurt kohn

Cancer research, 1981

View PDFchevron_right

Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cellsin vitro and in xenografts

Claudia Colussi

International Journal of Cancer, 2000

View PDFchevron_right

Molecular mechanisms of vincristine and paclitaxel resistance in mcf-7 cell line

Meltem Kars

2008

View PDFchevron_right

Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity

T. Stevnsner

Carcinogenesis, 1996

View PDFchevron_right

DNA excision-repair synthesis is enhanced in a murine leukemia L1210 cell line resistant to cisplatin

Jean-Marc Barret

European Journal of Biochemistry, 1993

View PDFchevron_right

Dissimilar invasive and metastatic behavior of vincristine and doxorubicin-resistant cell lines derived from a murine T cell lymphoid leukemia

Mariana Garcia, Mariana Garcı́a, Glenda Ernst, Silvia Hajos

2002

View PDFchevron_right

Selective Enhancement of Vincristine Cytotoxicity in Multidrug-resistant l\imor Cells by Dilantin (Phenytoin)1

Aleck Hercbergs

2000

View PDFchevron_right

DNA Damage-Processing Pathways Involved in the Eukaryotic Cellular Response to Anticancer DNA Cross-Linking Drugs

Paul Doetsch

Molecular Pharmacology, 2004

View PDFchevron_right

The mismatch repair-mediated cell cycle checkpoint response to fluorodeoxyuridine

Vincenzo Salerno

Journal of Cellular Biochemistry, 2008

View PDFchevron_right

Balancing repair and tolerance of DNA damage caused by alkylating agents

Leona Samson

Nature Reviews Cancer, 2012

View PDFchevron_right

Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BWAtypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Cancer Res 49: 5281-5287

Les White

Cancer Research

View PDFchevron_right

Enhanced host cell reactivation capacity and expression of DNA repair genes in human breast cancer cells resistant to bi-functional alkylating agents

Sankar Mitra

Mutation Research/DNA Repair, 1995

View PDFchevron_right

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein

Ross Davey

PubMed, 1989

View PDFchevron_right

Screening of Pesticides with the Potential of Inducing DSB and Successive Recombinational Repair

Regina Montero Montoya

Journal of Toxicology, 2017

View PDFchevron_right

Effect of DNA Repair Deficiencies on the Cytotoxicity of Drugs Used in Cancer Therapy - A Review

Santiago Cordero

Current Medicinal Chemistry, 2014

View PDFchevron_right

Comparisons Between DT40 Wild Type and DT40-Cre1 Cells as Suitable Model Systems for Studying the DNA Damage Response

Noel Lowndes

Cell Cycle, 2007

View PDFchevron_right

Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil?

Ekram Saleh

Anti-Cancer Drugs, 2010

View PDFchevron_right

Tunicamycin potentiates drug cytotoxicity and vincristine retention in multidrug resistant cell lines

Donavon Hiss

European Journal of Cancer, 1996

View PDFchevron_right

Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity

Kumar Sanjiv

Oncogene, 2013

View PDFchevron_right

Reversal of P-glycoprotein mediated vincristine resistance of L1210/VCR cells by analogues of pentoxifylline

Zuzana Drobna

European Journal of Pharmaceutical Sciences, 2004

View PDFchevron_right

Mechanisms of resistance to combinations of vincristine, etoposide and doxorubicin in Chinese hamster ovary cells

Jean-Yves CHARCOSSET

British Journal of Cancer, 1995

View PDFchevron_right